Trial Profile
An Open Label, Proof of Concept Study, to Evaluate the Safety and Biological Effects of Oxycyte Perfluorocarbon in Patients With A Severe Head Injury Requiring Intracranial Pressure Monitoring-OX-CL-II-002
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2014
Price :
$35
*
At a glance
- Drugs Perfluorocarbon (Primary)
- Indications Traumatic brain injuries
- Focus Proof of concept; Therapeutic Use
- Sponsors Tenax Therapeutics
- 29 Sep 2014 New trial record